Diabetic kidneys do deserve a lifestyle change

Affiliations

¹ National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases, AZ, USA.
² Wake Forest School of Medicine, Wake Forest Baptist Medical Center, Winston-Salem, NC 27157-1090, USA. Electronic address: jbahnson@wakehealth.edu.
³ Department of Medicine, University of Minnesota, MN, USA.
⁴ University of Alabama at Birmingham, AL, USA.

Comment

William C Knowler et al. Lancet Diabetes Endocrinol. 2014 Oct.

. 2014 Oct;2(10):776.

doi: 10.1016/S2213-8587(14)70204-9.

¹ National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases, AZ, USA.
² Wake Forest School of Medicine, Wake Forest Baptist Medical Center, Winston-Salem, NC 27157-1090, USA. Electronic address: jbahnson@wakehealth.edu.
³ Department of Medicine, University of Minnesota, MN, USA.
⁴ University of Alabama at Birmingham, AL, USA.

No abstract available

Comment on

Do diabetic kidneys deserve a lifestyle change?
de Zeeuw D, Lambers Heerspink H. de Zeeuw D, et al. Lancet Diabetes Endocrinol. 2014 Oct;2(10):769-70. doi: 10.1016/S2213-8587(14)70163-9. Epub 2014 Aug 10. Lancet Diabetes Endocrinol. 2014. PMID: 25127481 No abstract available.
Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial.
Look AHEAD Research Group. Look AHEAD Research Group. Lancet Diabetes Endocrinol. 2014 Oct;2(10):801-9. doi: 10.1016/S2213-8587(14)70156-1. Epub 2014 Aug 10. Lancet Diabetes Endocrinol. 2014. PMID: 25127483 Free PMC article. Clinical Trial.

1. The Look AHEAD Research Group: Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomized clinical trial. Lancet Diabetes and Endocrinology e-pub August 11, 2014. - PMC - PubMed
1. The Look AHEAD Research Group: Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. New England Journal of Medicine 369: 145–154, 2013. - PMC - PubMed
1. Roscioni SS, Lambers Heerspink HJ, de Zeeuw D: Microalbuminuria: target for renoprotective therapy PRO. Kidney International 86: 40–49, 2014. - PubMed
2. The Look AHEAD Research Group, prepared by William C. Knowler, Judy L. Bahnson, John P. Bantle, and Cora E. Lewis